Scientists discover fungus-based silver nanoparticles that could fight COVID-19
Researchers from the University of São Paulo in Brazil have discovered that silver nanoparticles produced by a fungus called Trichoderma reesei might be an...
One in 3,000 people may carry a gene that can deflate a lung, warns...
New research from the University of Cambridge reveals that a gene fault linked to a rare condition may be far more common than doctors...
Drug cocktail could work against viruses behind colds, meningitis, and more
Enteroviruses are a large group of viruses that can cause a wide range of illnesses—from the common cold to serious conditions like meningitis, polio,...
Most COVID-19 treatments are safe and rarely cause serious side effects, study finds
A new study has found that most COVID-19 treatments approved in the United States are safe and not linked to serious side effects.
Researchers at...
Chewing gum made from beans could help stop the spread of flu and herpes
Scientists at the University of Pennsylvania have developed an antiviral chewing gum that may help reduce the spread of common viruses like influenza and...
New COVID pill may work better than Paxlovid without side effects
Researchers at Rutgers University have created a new antiviral drug for COVID-19 that could be safer and more effective than Paxlovid, the current leading...
New COVID-19 pill shows strong protection against tougher virus strains
Scientists at Rutgers Health have developed a new COVID-19 drug that could be a powerful alternative to Paxlovid, the most commonly used oral treatment...
Pregnancy could help lower the risk of long COVID, study finds
Pregnant women may have a lower chance of developing long COVID, according to a new study published on April 1 in Nature Communications.
The research...
A new COVID variant is on the rise. Here’s what to know about LP.8.1
More than five years since COVID was declared a pandemic, we’re still facing the regular emergence of new variants of the virus, SARS-CoV-2.
The latest...
Long COVID affects nearly 1 in 4 and can last for years, study finds
A new population-based study from Spain reveals that nearly 23% of people infected with COVID-19 between 2021 and 2023 went on to develop long...